chr1-8958997-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001215.4(CA6):c.496G>A(p.Val166Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000331 in 1,599,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001215.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA6 | NM_001215.4 | c.496G>A | p.Val166Ile | missense_variant | 4/8 | ENST00000377443.7 | NP_001206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA6 | ENST00000377443.7 | c.496G>A | p.Val166Ile | missense_variant | 4/8 | 1 | NM_001215.4 | ENSP00000366662.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250834Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135536
GnomAD4 exome AF: 0.0000256 AC: 37AN: 1447604Hom.: 0 Cov.: 27 AF XY: 0.0000250 AC XY: 18AN XY: 721038
GnomAD4 genome AF: 0.000105 AC: 16AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.496G>A (p.V166I) alteration is located in exon 4 (coding exon 4) of the CA6 gene. This alteration results from a G to A substitution at nucleotide position 496, causing the valine (V) at amino acid position 166 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at